Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$589.4M+20.5%$752.5M+66.1%$647M+67.0%$546.05M+72.1%$489M+46.9%
$51.52M+187%$22.84M+61.0%$25.58M+10.7%$19.22M-35.1%$17.96M-54.4%
$398.64M+12.7%$396.39M+21.1%$382.63M+20.1%$363.49M+19.5%$353.66M+24.1%
$5.28M-17.3%$5.36M-25.6%$6.88M-0.5%$6.1M+8.1%$6.38M+9.0%
$778.82M+21.2%$907.01M+56.6%$838.8M+60.6%$691.35M+50.8%$642.69M+34.0%
$83.46M-22.2%$89.42M-21.1%$95.38M-20.0%$101.34M-19.0%$107.3M-18.2%
$493.01M+19.4%$364.62M-13.2%$369.42M-8.9%$416.65M+4.2%$412.84M+12.3%
$1.27B+20.5%$1.27B+27.3%$1.21B+30.2%$1.11B+29.1%$1.06B+24.6%
$28.6M+63.8%$17.69M+28.7%$26.34M+150%$28.3M+24.8%$17.46M+15.3%
$20M+14.3%$20M+23.1%$20M+33.3%$18.75M+25.0%$17.5M+16.7%
$217.34M+24.1%$252.13M+44.0%$223.4M+38.5%$180.14M+22.9%$175.12M+13.5%
$138.81M-12.2%$143.66M-11.9%$148.51M-11.5%$153.35M-10.5%$158.18M-9.6%
$144.14M-9.9%$149.28M-9.5%$149.69M-12.0%$154.79M-10.6%$159.89M-9.8%
$361.48M+7.9%$401.41M+18.0%$373.1M+12.6%$334.93M+4.7%$335.01M+1.0%
$1K0.0%$1K0.0%$1K0.0%$1K0.0%$1K0.0%
$193.39M+305%$160.9M+7,161%$138.42M+393%$87.55M+194%$47.78M+146%
$910.35M+26.3%$870.22M+32.0%$835.12M+39.9%$773.08M+43.5%$720.53M+39.8%
$1.27B+20.5%$1.27B+27.3%$1.21B+30.2%$1.11B+29.1%$1.06B+24.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Can Harmony Biosciences Holdings, Inc. cover its short-term obligations?
Its current ratio is 3.58 — current assets exceed current liabilities.
Where does Harmony Biosciences Holdings, Inc.'s balance sheet data come from?
Every line is extracted from Harmony Biosciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.